HK Stock MarketDetailed Quotes

02096 SIMCERE PHARMA

Watchlist
  • 6.840
  • +0.160+2.40%
Trading Nov 27 15:35 CST
17.28BMarket Cap-14309P/E (TTM)

SIMCERE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY
2024/H1
Stock NameRevenueRatio
Drug sales2.96B94.93%
Income from extension services130.4M4.19%
Revenue from R & D services27.51M0.88%
Product

No Data

Region

No Data

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data